Discover and read the best of Twitter Threads about #duplication
Most recents (4)
Finally, the #GoldacreReview is published! (During Parliamentary Easter holidays, mid-ping-pong on the #HealthAndCareBill...)
It's 221 pages - each PDF page is a double page spread - so this could be a lo-o-o-ong [Thread].
Here goes...
It's 221 pages - each PDF page is a double page spread - so this could be a lo-o-o-ong [Thread].
Here goes...
First point to note, in the Terms of Reference (p5), is that this is about "access to #NHSdata by #researchers, #commissioners, and #innovators" - i.e. #Planning and #CommercialReUse - so it is directly relevant to the operation of millions of people's #NationalDataOptOuts... 
"185 wide-ranging recommendations for us to explore", says @sajidjavid (p6). Gulp! Time for some coffee...
"systems that ensure #underrepresented groups are well represented" may (partly) refer to this "landmark review", which got off to a slow start:
gov.uk/government/new…
"systems that ensure #underrepresented groups are well represented" may (partly) refer to this "landmark review", which got off to a slow start:
gov.uk/government/new…
(1/7) A quality control tool for raw #sequence data. Using #FastQC you may check:
🚀 Per base sequence #quality (do you see a drop in sequencing quality near the read end?). This view shows an overview of the range of quality across all bases at each position in the FASTQ file.
🚀 Per base sequence #quality (do you see a drop in sequencing quality near the read end?). This view shows an overview of the range of quality across all bases at each position in the FASTQ file.
(2/7) Per sequence quality scores (how many reads are the best?) The per sequence quality score report shows whether a subset of sequences has universally low-quality values.
(3/7) Per base sequence content (the proportion of each base position in a file for which each of the four normal #DNA bases has been called). Ideally, in a random library, we would see four parallel lines representing the relative base composition.
#Infodemic. There are a lot of new papers/webinars every day 'bout #COVID. Are we ready to consume them?
@EvidNutrition @EBaladia @renhyd_org @emnavarretem @Macarena_LL @nut_saby @Nutrir_Mexico @EveApolinar @MariaMarquesDN @buhringk @eliud_aguilarb
sciencemag.org/news/2020/05/s…
@EvidNutrition @EBaladia @renhyd_org @emnavarretem @Macarena_LL @nut_saby @Nutrir_Mexico @EveApolinar @MariaMarquesDN @buhringk @eliud_aguilarb
sciencemag.org/news/2020/05/s…
1) New tools as #DataMining could help, but!
2) We need #quality not #quantity
3) A lot of papers are useless
4) And other more are unknown to the scientific groups
➡️We have a lot of work to do.
2) We need #quality not #quantity
3) A lot of papers are useless
4) And other more are unknown to the scientific groups
➡️We have a lot of work to do.
There are more. Thx to @EBaladia for share this: Waste in COVID-19 research by @PaulGlasziou/@bmj_latest bmj.com/content/369/bm…
❌A lot of trials How about quality?
❌Preprints A huge situation
❌Duplication Big problem
@nutriologaedna @MagdaRamrez8 @EvidNutrition @UrsuliuxMed
❌A lot of trials How about quality?
❌Preprints A huge situation
❌Duplication Big problem
@nutriologaedna @MagdaRamrez8 @EvidNutrition @UrsuliuxMed
First completed systematic review on antimalarials (#hydrochloroquine #chloroquine) for #Covid_19
It is a rigorous SR conducted rapidly, NOT a rapid review (less rigour)
Submitted today to journal but preliminary report here to avoid delay in decision-making (1/4🧵)
It is a rigorous SR conducted rapidly, NOT a rapid review (less rigour)
Submitted today to journal but preliminary report here to avoid delay in decision-making (1/4🧵)
For others to replicate, we share search strategy and downloadable files
Published and ongoing studies continuously updated here:
app.iloveevidence.com/loves/5e6fdb96…
Let's advocate for #replication not #duplication (waste) in evidence synthesis.
Also, collaboration more than welcome (2/4🧵)
Published and ongoing studies continuously updated here:
app.iloveevidence.com/loves/5e6fdb96…
Let's advocate for #replication not #duplication (waste) in evidence synthesis.
Also, collaboration more than welcome (2/4🧵)
It includes first RCT with reported data.
It has negative findings. Portrays different picture than questionable study hitting the news days ago (Gautret et al)
Thanks to @ConfucioUST for translation (Chinese to English). We are exploring copyright issues before sharing
(3/4🧵)
It has negative findings. Portrays different picture than questionable study hitting the news days ago (Gautret et al)
Thanks to @ConfucioUST for translation (Chinese to English). We are exploring copyright issues before sharing
(3/4🧵)
